Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Oncofertility
  • Reduced price
Psychiatric Drugs Explained

Psychiatric Drugs Explained

9780702083907
171.31 zł
145.61 zł Save 25.70 zł Tax included
Lowest price within 30 days before promotion: 145.61 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

Psychiatric Drugs Explained offers a wealth of evidence-based information on psychiatric drugs in an easy-to-use format that can be quickly referenced in the clinical setting.

Written by internationally recognised author Dr David Healy, the book provides a comprehensive review of drug effects, action and side-effects. There is an emphasis on the lived experience of patients, providing the reader with a sense of what the adverse effects of drugs might feel like to those who use them.

A reader-friendly approach and clear layout, with information organised by disorder, make this popular title accessible and useful not only to nursing staff, but to all members of the multidisciplinary team.

Product Details
Elsevier
92600
9780702083907
9780702083907

Data sheet

Publication date
2022
Issue number
7
Cover
paperback
Pages count
356
Dimensions (mm)
152 x 229
Weight (g)
590

  • Section 1 Management of the psychoses

    2 The antipsychotics

    3 Antipsychotic side effects and their management

    References

    Section 2 Management of depression

    4 The antidepressants

    5 Side effects of antidepressants

    References

    Section 3 Management of bipolar disorders

    6 Management of acute bipolar disorder

    7 Mood-stabilisers

    References

    Section 4 Stimulants & Drugs for children

    8 Stimulants & Drugs for children

    References

    Section 5 Management of anxiety

    8 The anxiety disorders

    10 Benzodiazepine anxiolytics

    11 Anxiolysis and the serotonin system

    12 Beta-blockers and anxiety

    References

    Section 6 Management of sleep disorders and insomnia

    13 Sleep disorders and insomnia

    14 Non-pharmacological management of insomnia

    15 Hypnotics

    16 Sedatives

    References

    Section 7 Management of cognitive impairment

    17 Cognitive enhancement and the dementias

    18 Cognitive enhancement and neuroprotection

    References

    Section 8 Management of sexual difficulties

    19 The range of sexual difficulties

    20 Effects of drugs on aspects of sexual functioning

    Appendix 20.1 Male sexual functioning questionnaire

    Appendix 20.2 Female sexual functioning questionnaire

    References

    Section 9 Management of dependence and withdrawal

    21 Dependence & Withdrawal

    22 Dependence & Craving

    23 Dependence & Protracted Withdrawal

    References

    Section 10 Consent, abuse and liability

    24 Consent

    25 Pharmacological abuse

    References

    Section 11 The marketing of tranquillity

    26 The ethical industry

    27 Evidence-biased care

    28 Marketing & Risk

    29 From healthcare to pharmageddon

Comments (0)